Abstract
Choroidal melanoma is a rare malignant tumour, yet it is the most common primary intra-ocular neoplasm and second on the list of top ten most malignant melanoma sites in the body. Clinical presentation can be non-specific and includes photopsia, floaters, progressive visual field loss, and blurry vision. The tumour is quite often diagnosed clinically during fundus examination; however, the most valued diagnostic tests are A- and B-scan ultrasonography (US). Several factors affect prognosis, including the patient’s age, tumour size, histological features, and presence of metastases. Still, with primary treatment and tight surveillance, around 50% of choroidal melanoma patients metastasise.
Reference67 articles.
1. Choroidal melanoma;Singh;Oman J. Ophthalmol.,2012
2. Treatment of uveal melanoma: Where are we now?;Yang;Ther. Adv. Med. Oncol.,2018
3. Violanti, S.S., Bononi, I., Gallenga, C.E., Martini, F., Tognon, M., and Perri, P. (2019). New insights into molecular oncogenesis and therapy of uveal melanoma. Cancers, 11.
4. Uveal melanoma: Epidemiology, etiology, and treatment of primary disease;Krantz;Clin. Ophthalmol.,2017
5. Advanced choroidal melanoma with a desirable aesthetic outcome after enucleation: A case report;Terzidou;Oncol. Lett.,2018
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献